PP01.72 Randomized Phase-3 Study: Tarlatamab, a DLL3-targeting Bispecific T-cell engager (BiTE), Compared to Standard-of-Care in Relapsed Small Cell Lung Cancer (DeLLphi-304)
医学
护理标准
肺癌
肿瘤科
癌症研究
非小细胞肺癌
内科学
A549电池
作者
Luis Paz-Ares Rodríguez,Enriqueta Felip,Myung‐Ju Ahn,Fiona Blackhall,Hossein Borghaei,Byoung Chul Cho,Melissa L. Johnson,Suresh S. Ramalingam,Martin Reck,Tony T. Jiang,Chia‐Hsin Ju,Mukul Minocha,Sujoy Mukherjee,Gaurav Suri,G. Recondo,Pablo Martínez